Evan R Abt

5PUBLICATIONS
26CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 20, 2026
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade.

Evan R Abt, Liang Wang, Grigor Varuzhanyan

|Nov 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity.

Grigor Varuzhanyan, Chia-Chun Chen, Jack Freeland

|Nov 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.

Evan R Abt, Alex K Lam, Miyako Noguchi

|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.

Razmik Ghukasyan, Keke Liang, Kevin Chau

|Sep 04, 2021
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging.

Keke Liang, Evan R Abt, Thuc M Le

Pageof 1